USD 8.2
(-0.97%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 755.65 Thousand USD | -38.52% |
2022 | 1.22 Million USD | -59.33% |
2021 | 3.02 Million USD | 1670.79% |
2020 | 170.68 Thousand USD | -87.29% |
2019 | 1.34 Million USD | -69.86% |
2018 | 4.45 Million USD | 2.77% |
2017 | 4.33 Million USD | 54.71% |
2016 | 2.8 Million USD | -27.14% |
2015 | 3.84 Million USD | -82.0% |
2014 | 21.35 Million USD | 5.49% |
2013 | 20.24 Million USD | 0.0% |
2012 | - USD | -100.0% |
2011 | 14.05 Million USD | -48.69% |
2010 | 27.39 Million USD | 145.41% |
2009 | 11.16 Million USD | -17.22% |
2008 | 13.48 Million USD | 256.48% |
2007 | 3.78 Million USD | 8.59% |
2006 | 3.48 Million USD | -50.83% |
2005 | 7.08 Million USD | 72.21% |
2004 | 4.11 Million USD | 64.39% |
2003 | 2.5 Million USD | 74.48% |
2002 | 1.43 Million USD | 43.4% |
2001 | 1 Million USD | -43.67% |
2000 | 1.77 Million USD | -27.35% |
1999 | 2.44 Million USD | 16.37% |
1998 | 2.1 Million USD | -16.0% |
1997 | 2.5 Million USD | 56.25% |
1996 | 1.6 Million USD | 0.0% |
1995 | 1.6 Million USD | -58.97% |
1994 | 3.9 Million USD | -13.33% |
1993 | 4.5 Million USD | -53.61% |
1992 | 9.7 Million USD | 6.59% |
1991 | 9.1 Million USD | 62.5% |
1990 | 5.6 Million USD | -28.21% |
1989 | 7.8 Million USD | -30.97% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 1.64 Million USD | 0.0% |
2024 Q1 | 1.64 Million USD | 118.31% |
2023 Q3 | 755.65 Thousand USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | -100.0% |
2023 Q4 | 755.65 Thousand USD | 0.0% |
2023 FY | 755.65 Thousand USD | -38.52% |
2022 FY | 1.22 Million USD | -59.33% |
2022 Q2 | 2.79 Million USD | 0.0% |
2022 Q4 | 1.22 Million USD | 0.0% |
2022 Q3 | 1.22 Million USD | -56.07% |
2022 Q1 | 2.79 Million USD | -7.42% |
2021 Q1 | 2.14 Million USD | 1158.43% |
2021 FY | 3.02 Million USD | 1670.79% |
2021 Q2 | 1.51 Million USD | -29.44% |
2021 Q3 | 3.73 Million USD | 146.64% |
2021 Q4 | 3.02 Million USD | -19.15% |
2020 Q3 | 797.68 Thousand USD | -11.83% |
2020 FY | 170.68 Thousand USD | -87.29% |
2020 Q4 | 170.68 Thousand USD | -78.6% |
2020 Q1 | 3.72 Million USD | 177.55% |
2020 Q2 | 904.72 Thousand USD | -75.72% |
2019 Q3 | 1.34 Million USD | -69.47% |
2019 FY | 1.34 Million USD | -69.86% |
2019 Q1 | 4.39 Million USD | -1.29% |
2019 Q2 | 4.39 Million USD | 0.0% |
2019 Q4 | 1.34 Million USD | 0.0% |
2018 Q1 | 4.36 Million USD | 0.65% |
2018 FY | 4.45 Million USD | 2.77% |
2018 Q4 | 4.45 Million USD | 0.0% |
2018 Q3 | 4.45 Million USD | 2.11% |
2018 Q2 | 4.36 Million USD | 0.0% |
2017 Q1 | 5.96 Million USD | 112.82% |
2017 Q2 | 4.06 Million USD | -31.76% |
2017 Q3 | 5.42 Million USD | 33.43% |
2017 Q4 | 4.33 Million USD | -20.16% |
2017 FY | 4.33 Million USD | 54.71% |
2016 Q3 | 4.98 Million USD | 129.02% |
2016 Q4 | 2.8 Million USD | -43.8% |
2016 Q1 | 4.67 Million USD | 21.63% |
2016 Q2 | 2.17 Million USD | -53.45% |
2016 FY | 2.8 Million USD | -27.14% |
2015 Q3 | 6.29 Million USD | -20.72% |
2015 Q2 | 7.93 Million USD | -30.3% |
2015 Q1 | 11.38 Million USD | -46.68% |
2015 Q4 | 3.84 Million USD | -38.9% |
2015 FY | 3.84 Million USD | -82.0% |
2014 Q1 | 17.17 Million USD | -15.16% |
2014 Q2 | 17.17 Million USD | 0.0% |
2014 FY | 21.35 Million USD | 5.49% |
2014 Q3 | 21.35 Million USD | 24.33% |
2014 Q4 | 21.35 Million USD | 0.0% |
2013 Q3 | 20.24 Million USD | 12.56% |
2013 Q2 | 17.98 Million USD | 0.0% |
2013 FY | 20.24 Million USD | 0.0% |
2013 Q1 | 17.98 Million USD | 0.0% |
2013 Q4 | 20.24 Million USD | 0.0% |
2012 FY | - USD | -100.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q3 | 8.15 Million USD | -78.51% |
2011 FY | 14.05 Million USD | -48.69% |
2011 Q4 | 14.05 Million USD | 72.26% |
2011 Q1 | 33.74 Million USD | 23.19% |
2011 Q2 | 37.96 Million USD | 12.49% |
2010 FY | 27.39 Million USD | 145.41% |
2010 Q3 | 19.62 Million USD | 1.21% |
2010 Q2 | 19.39 Million USD | -21.11% |
2010 Q1 | 24.58 Million USD | 120.26% |
2010 Q4 | 27.39 Million USD | 39.54% |
2009 Q2 | 16.16 Million USD | -13.59% |
2009 FY | 11.16 Million USD | -17.22% |
2009 Q1 | 18.7 Million USD | 38.71% |
2009 Q3 | 11.99 Million USD | -25.76% |
2009 Q4 | 11.16 Million USD | -6.96% |
2008 FY | 13.48 Million USD | 256.48% |
2008 Q4 | 13.48 Million USD | 398.52% |
2008 Q3 | 2.7 Million USD | 117.69% |
2008 Q2 | 1.24 Million USD | -59.28% |
2008 Q1 | 3.05 Million USD | -19.33% |
2007 Q2 | 3.74 Million USD | -70.6% |
2007 Q3 | 603.91 Thousand USD | -83.88% |
2007 Q4 | 3.78 Million USD | 526.29% |
2007 FY | 3.78 Million USD | 8.59% |
2007 Q1 | 12.74 Million USD | 265.91% |
2006 FY | 3.48 Million USD | -50.83% |
2006 Q2 | 5.61 Million USD | -3.94% |
2006 Q1 | 5.84 Million USD | -17.41% |
2006 Q3 | 4.23 Million USD | -24.7% |
2006 Q4 | 3.48 Million USD | -17.69% |
2005 Q4 | 7.08 Million USD | -9.2% |
2005 Q2 | 6.54 Million USD | 48.82% |
2005 Q1 | 4.39 Million USD | 6.89% |
2005 FY | 7.08 Million USD | 72.21% |
2005 Q3 | 7.8 Million USD | 19.23% |
2004 Q4 | 4.11 Million USD | -6.4% |
2004 Q3 | 4.39 Million USD | 8.78% |
2004 FY | 4.11 Million USD | 64.39% |
2004 Q1 | 2.86 Million USD | 14.43% |
2004 Q2 | 4.03 Million USD | 41.1% |
2003 Q2 | 2.63 Million USD | 36.97% |
2003 FY | 2.5 Million USD | 74.48% |
2003 Q4 | 2.5 Million USD | -7.63% |
2003 Q3 | 2.7 Million USD | 2.87% |
2003 Q1 | 1.92 Million USD | 34.07% |
2002 Q2 | 730.31 Thousand USD | 1.51% |
2002 Q1 | 719.48 Thousand USD | -28.05% |
2002 Q3 | 909.79 Thousand USD | 24.57% |
2002 Q4 | 1.43 Million USD | 57.62% |
2002 FY | 1.43 Million USD | 43.4% |
2001 Q3 | 1.96 Million USD | -0.88% |
2001 Q2 | 1.98 Million USD | 5.3% |
2001 Q1 | 1.88 Million USD | 6.22% |
2001 FY | 1 Million USD | -43.67% |
2001 Q4 | 1 Million USD | -49.19% |
2000 Q3 | 1.75 Million USD | -33.4% |
2000 Q2 | 2.63 Million USD | 3.08% |
2000 Q1 | 2.55 Million USD | 4.68% |
2000 FY | 1.77 Million USD | -27.35% |
2000 Q4 | 1.77 Million USD | 1.1% |
1999 Q2 | 2 Million USD | 17.65% |
1999 FY | 2.44 Million USD | 16.37% |
1999 Q3 | 2.1 Million USD | 5.0% |
1999 Q4 | 2.44 Million USD | 16.37% |
1999 Q1 | 1.7 Million USD | -19.05% |
1998 Q3 | 1.7 Million USD | 41.67% |
1998 Q2 | 1.2 Million USD | 0.0% |
1998 FY | 2.1 Million USD | -16.0% |
1998 Q1 | 1.2 Million USD | -52.0% |
1998 Q4 | 2.1 Million USD | 23.53% |
1997 Q3 | 2.6 Million USD | -25.71% |
1997 Q2 | 3.5 Million USD | 191.67% |
1997 Q1 | 1.2 Million USD | -25.0% |
1997 FY | 2.5 Million USD | 56.25% |
1997 Q4 | 2.5 Million USD | -3.85% |
1996 Q2 | 700 Thousand USD | 133.33% |
1996 Q4 | 1.6 Million USD | 14.29% |
1996 Q3 | 1.4 Million USD | 100.0% |
1996 Q1 | 300 Thousand USD | -81.25% |
1996 FY | 1.6 Million USD | 0.0% |
1995 Q1 | 2.7 Million USD | -30.77% |
1995 FY | 1.6 Million USD | -58.97% |
1995 Q4 | 1.6 Million USD | -46.67% |
1995 Q3 | 3 Million USD | 25.0% |
1995 Q2 | 2.4 Million USD | -11.11% |
1994 FY | 3.9 Million USD | -13.33% |
1994 Q3 | 2.7 Million USD | -43.75% |
1994 Q1 | 3.9 Million USD | -13.33% |
1994 Q2 | 4.8 Million USD | 23.08% |
1994 Q4 | 3.9 Million USD | 44.44% |
1993 Q4 | 4.5 Million USD | -26.23% |
1993 Q3 | 6.1 Million USD | -12.86% |
1993 FY | 4.5 Million USD | -53.61% |
1993 Q1 | 8.1 Million USD | -16.49% |
1993 Q2 | 7 Million USD | -13.58% |
1992 Q4 | 9.7 Million USD | 29.33% |
1992 Q3 | 7.5 Million USD | 0.0% |
1992 FY | 9.7 Million USD | 6.59% |
1992 Q1 | 11.4 Million USD | 25.27% |
1992 Q2 | - USD | -100.0% |
1991 Q3 | 8.6 Million USD | 0.0% |
1991 Q4 | 9.1 Million USD | 5.81% |
1991 Q1 | 9.7 Million USD | 73.21% |
1991 FY | 9.1 Million USD | 62.5% |
1990 Q2 | 7.5 Million USD | 4.17% |
1990 Q3 | 5.7 Million USD | -24.0% |
1990 Q4 | 5.6 Million USD | -1.75% |
1990 Q1 | 7.2 Million USD | -7.69% |
1990 FY | 5.6 Million USD | -28.21% |
1989 FY | 7.8 Million USD | -30.97% |
1989 Q4 | 7.8 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | 99.118% |
AngioDynamics, Inc. | 5.91 Million USD | 87.223% |
AtriCure, Inc. | 74.49 Million USD | 98.986% |
Avinger, Inc. | 15.39 Million USD | 95.092% |
Azenta, Inc. | 60.43 Million USD | 98.75% |
BioLife Solutions, Inc. | 42.69 Million USD | 98.23% |
The Cooper Companies, Inc. | 2.56 Billion USD | 99.971% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | 89.458% |
Femasys Inc. | 6.7 Million USD | 88.723% |
GlucoTrack, Inc. | 196 Thousand USD | -285.54% |
Harvard Bioscience, Inc. | 42.77 Million USD | 98.233% |
Hologic, Inc. | 2.53 Billion USD | 99.97% |
ICU Medical, Inc. | 1.7 Billion USD | 99.956% |
Intuitive Surgical, Inc. | 89.8 Million USD | 99.159% |
KORU Medical Systems, Inc. | 4.44 Million USD | 83.0% |
LeMaitre Vascular, Inc. | 19.09 Million USD | 96.043% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | 99.922% |
Microbot Medical Inc. | 231 Thousand USD | -227.125% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | 89.692% |
Merit Medical Systems, Inc. | 891.35 Million USD | 99.915% |
Nephros, Inc. | 1.83 Million USD | 58.842% |
NovoCure Limited | 596.24 Million USD | 99.873% |
NEXGEL, Inc. | 2.79 Million USD | 72.993% |
NEXGEL, Inc. | 2.79 Million USD | 72.993% |
Singular Genomics Systems, Inc. | 75.28 Million USD | 98.996% |
OraSure Technologies, Inc. | 13.5 Million USD | 94.404% |
Pro-Dex, Inc. | 13.54 Million USD | 94.422% |
Pulse Biosciences, Inc. | 9.14 Million USD | 91.736% |
Predictive Oncology Inc. | 2.85 Million USD | 73.549% |
Precision Optics Corporation, Inc. | 3.43 Million USD | 77.998% |
QuidelOrtho Corporation | 2.61 Billion USD | 99.971% |
Repligen Corporation | 711.8 Million USD | 99.894% |
Sanara MedTech Inc. | 11.79 Million USD | 93.592% |
STAAR Surgical Company | 35.83 Million USD | 97.891% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -120.953% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.967% |
Jin Medical International Ltd. | 4.11 Million USD | 81.628% |